PerkinElmer enables scientists, researchers and clinicians to address their most critical challenges across science and healthcare. With a mission focused on innovating for a healthier world, we deliver unique solutions to serve the diagnostics, life sciences, food and applied markets. We strategically partner with customers to enable earlier and more accurate insights supported by deep market knowledge and technical expertise. Our dedicated team of 12,500 employees worldwide is passionate about helping customers work to create healthier families, improve the quality of life, and sustain the well-being and longevity of people globally.
Mission:
Innovating for a healthier world
Ticker Symbol:
PKI (NYSE)
2018 Revenue:
Approximately $2.8 billion
Chairman & CEO:
Robert F. Friel
Capabilities:
Detection
Imaging
Informatics
Services
Serving:
Clinical
Pharmaceutical
Food
Environmental
Industrial
Global Headquarters:
Waltham, MA
Number of Patents:
3,500
Together, we are making a difference for the better:
*PerkinElmer conducts business in nearly every country across the globe.
*Excluding the following countries that are currently restricted due to embargo and/or sanctions: Cuba, Iran, North Korea, Sudan and Syria